Effect of Overlapping Insulin Glargine Administration in Decreasing Incidence of Hyperglycemia after Discontinuation of Intravenous Insulin Infusion

This study is an Institutional Review Board-approved retrospective chart review. Patients were included if they between the ages of 18 and 89, admitted 3/1/20 12/31/21, received IV insulin infusion for at least 24 hours, previously diagnosed with type I or II diabetes. who did not receive glargine those diabetic ketoacidosis hyperosmolar hyperglycemia syndrome on admission excluded. Electronic medical record reports built to identify patients that SC glargine.